Showing results (451-460 of 530) with videos related to

Sort By:
Pageof 53
JCO Precision Oncology|June 1, 2023
Prevalence and Clinical Implications of Mismatch Repair-Proficient Colorectal Cancer in Patients With Lynch SyndromeMegha Ranganathan, Rosalba E Sacca, Magan Trottier, et al.
JAMA Oncology|July 7, 2018
Prevalence of Germline Mutations in Cancer Susceptibility Genes in Patients With Advanced Renal Cell CarcinomaMaria I Carlo, Semanti Mukherjee, Diana Mandelker, et al.
Nature Medicine|January 3, 2025
Clinicogenomic landscape of pancreatic adenocarcinoma identifies KRAS mutant dosage as prognostic of overall survivalAnna M Varghese, Maria A Perry, Joanne F Chou, et al.
Plos Genetics|June 24, 2015
Germline ETV6 Mutations Confer Susceptibility to Acute Lymphoblastic Leukemia and ThrombocytopeniaSabine Topka, Joseph Vijai, Michael F Walsh, et al.
The Oncologist|March 12, 2022
Survival After Induction Chemotherapy and Chemoradiation Versus Chemoradiation and Adjuvant Chemotherapy for Locally Advanced Rectal CancerJin K Kim, Michael R Marco, Campbell S D Roxburgh, et al.
Translational Behavioral Medicine|September 28, 2013
Stakeholder perspectives on implementing the National Cancer Institute's patient-reported outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)Deborah Watkins Bruner, Laura J Hanisch, Bryce B Reeve, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 14, 2022
Inherited Germline Cancer Susceptibility Gene Variants in Individuals with Non-Muscle-Invasive Bladder CancerEugene J Pietzak, Karissa Whiting, Preethi Srinivasan, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 23, 2021
Multiple Primary Cancers in Patients Undergoing Tumor-Normal Sequencing Define Novel AssociationsYing L Liu, Karen A Cadoo, Semanti Mukherjee, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|April 10, 2015
PMS2 monoallelic mutation carriers: the known unknownMcKinsey L Goodenberger, Brittany C Thomas, Douglas Riegert-Johnson, et al.
Clinical Trials (London, England)|December 1, 2020
Composite grading algorithm for the National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)Ethan Basch, Claus Becker, Lauren J Rogak, et al.
Pageof 53